A recent research has found that the immune cells called natural killer (NK) cells may be used to develop future malaria vaccines. The NK cells are found among people living in areas where the parasite is common. The team identified a molecule that was essential for activation of NK cells in response to malaria-infected blood cells. PfEMP1 is crucial for activating NK cells in a manner dependent on antibodies.
More than 90% of India’s population is at the risk of a malaria infection, as compared to Bangladesh at 11% and Nepal at 48%. According to the National Vector Borne Disease Control Programme, last year, there were 840, 838 cases of malaria in India, while 103 people died due to the disease. Some tips:
— Courtesy: Heart Care Foundation of India